Douglas Medical Products Inc. (DMP) is an innovative medical device company manufacturing a full range of IV administrative single use disposable products. Engineering excellence and global manufacturing expertise enables us to leverage our current 510k’s to build product for our Douglas Medical Products brand as well as private label products for our partners.Douglas Medical Products, Inc. introduced the EcoFLX™ Product Line of DEHP/PVC-Free and EVA Empty IV Mixing Containers in May 2018. There has been excellent acceptance by customers from large Children’s Hospitals to small rural hospitals, 503B Compounders and home infusion companies across the US. All containers are PVC-Free/DEHP-Free/Latex-Free Extensive and full range of container sizes from 100mL to 5000mL Sterile, clear and flexible Tamper-evident medication site RELIABLE and NEW source of supply of empty IV containersTo set up an account to buy EcoFLX™: Call 1-844-323-9397 or email douglasmedical@foundcare.com Our full-service capability includes engineering, design, tooling, injection molding, high precision extrusion, insert molding, assembly operations, FFS packaging, testing, EtO sterilization and regulatory support.

Guard Your Staff® and Guard Your Patient® with our Guard360® line of securement products for infection prevention.PrimeGuard Medical will develop innovative new technologies to enhance infection control products. The initial family of products, our Guard360® line, is a patented platform of securement devices designed to create 360 degrees of stabilization for peripheral IV's and Foley catheters for use in hospitals, long-term care facilities and home care. Our next-generation Guard360® securement devices will help safeguard both patients and caregivers, reduce infection risks and lower healthcare providers costs. The new line of products are designed for care teams to successfully implement CDC Guidelines, OSHA, INS, APIC and WOCN Recommendations into their protocols and procedures and repurpose valuable caregivers time. • Establish OEM partnerships• GPO/DOD/VA/Hospital/Home Care Contracts• Strategic alliances for new disposable products• Develop hospital, long-term care facilities and direct to consumer sales & marketing strategy• Social selling, social prospecting, market awareness & branding

PrimeGuard Medical has a patented platform that utilizes new materials and offers unique features to both care team providers and patients. The initial family of products (Guard360®) is designed to secure peripheral IV’s and Foley catheters for use in hospitals, long term care facilities and patients in the home. The Guard360® line is designed to address the increasing occurrence of Hospital Acquired Infections such at Catheter Associated Urinary Tract Infections (CAUTI's) and as well as blood borne and fluid pathogens such as HIV, Ebola and TB. • Angel & VC fundraising• Beta test evaluations by clinicians and surgeons• Focus group review and product development• Present at VenturSHOT “Shark Tank” event in Chicago

Advisor and guidance for this not-for-profit organization towards continued outreach strategies to the life science industry, commercialization of drug and medical device repurposing projects being funded, and new revenue generating strategies to expand the scope of activities.

Datatrak is a worldwide technology and services company delivering end-to-end eClinical solutions in support of Phase I - Phase IV drug and device studies. Datatrak One® offers an advanced, robust, comprehensive, cloud-based clinical research platform. • Penetrate and up-sell full range of clinical trial services to pharmaceutical/medical device companies and CRO’s

Aggressively build a sales, marketing and distribution organization, for the start-up and initial launch of a disruptive new product(OcuMend) for the facial plastic surgery market. • Build out sales organization of a network of independent representatives• Design the distribution system to accept orders and integrate information • Develop brand for company and brand names for products (OcuMend) • Set up/implement the beta test program with 15 KOL facial and oculofacial surgeons (including 6 former Presidents of AAFPRS/CSFPS/ASOPRS) to successfully ready lead product for Q2 2012 launch

Eurand acquired SourceCF, to acquire existing sales organization and to launch first branded product to the cystic fibrosis community. • #1 in total company Zenpep Rx sales for 2010 launch year • Aptalis completed the acquisition of Eurand in December 2010

SourceCF was a start-up company with the mission to meet the unmet needs of the cystic fibrosis community. Started company with 2 partners. SourceCF developed internally designed products and was also the demand generation organization for other start-up companies that did not have their own internal sales teams. • Successfully launched 8 new pharmaceuticals, medical devices, nutritional and hardware products in highly competitive markets dominated by long standing market leaders• Eurand completed the acquisition of SourceCF in December 2007

Start-up PathoGenesis obtained FDA approval in December 1997 for TOBI, the first inhaled antibiotic for patients with Cystic Fibrosis. Key driver to support the dynamic and high growth sales organization. Sales exceeded $64 million in launch year.• Chiron completed the acquisition of PathoGenesis in May 2001.

Vice President of newly created Medical Device Division.• Developed/implemented procedures and protocols for all operations of newly created Medical Device Division (four existing products/companies) including regulatory, GMP, manufacturing, vendor relations, forecasting, production planning and inventory • Product development of new medical devices in base business, laboratory filtration and ambulatory chemotherapy infusion lines

Successfully started-up medical device company specializing in custom and single use disposable medical products. • Developed unique and innovative Lo-Profile® product lines made exclusively of non-DEHP materials, with all products made in the USA • Sold products in 32 states and was a federal government approved vendor

Product, P&L and marketing responsibilities for base IV business and new product launches, total sales over $140 million as Manager in Marketing. Strategic, Corporate Financial Operations & Engineering. • Successfully reinvigorated custom IV set business from $ 4 million to $ 13 million over three years• Multiple Corporate Awards for identifying new Corporate opportunities